Yew Bio-Pharm Group, Inc. Operating Lease Cost
Yew Bio-Pharm Group, Inc. reported Operating Lease Cost of $38.69 thousand for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2020-08-14
- Yew Bio-Pharm Group, Inc. operating lease, cost for the quarter ending 2020-06-30 was $19.37K, a 116.00% increase year-over-year.
- Yew Bio-Pharm Group, Inc. operating lease, cost for the quarter ending 2020-03-31 was $19.32K, a 34.54% decline year-over-year.
- Yew Bio-Pharm Group, Inc. operating lease, cost for the quarter ending 2019-12-31 was $15.19K.
- Yew Bio-Pharm Group, Inc. operating lease, cost for the quarter ending 2019-09-30 was $75.00K.
- Yew Bio-Pharm Group, Inc. operating lease, cost for fiscal 2019 was $128.66K.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2020-06-30 | $19.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $38.69K 10-Q · filed 2020-08-14 | $53.87K derived: sum of 3 quarters · filed 2020-08-14 | $128.87K derived: sum of 4 quarters · filed 2020-08-14 |
| 2020-03-31 | $19.32K 10-Q · filed 2020-06-29 | $34.51K derived: sum of 2 quarters · filed 2020-06-29 | $109.50K derived: sum of 3 quarters · filed 2020-06-29 | $118.47K derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-12-31 | $15.19K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-14 | $90.18K derived: sum of 2 quarters · filed 2020-05-14 | $99.15K derived: sum of 3 quarters · filed 2020-08-14 | $128.66K 10-K · filed 2020-05-14 |
| 2019-09-30 | $75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $83.96K derived: sum of 2 quarters · filed 2020-08-14 | $113.48K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $8.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $38.48K 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $29.51K 10-Q · filed 2020-06-29 |